Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Jan 29;2014(1):1.
doi: 10.5339/gcsp.2014.1. eCollection 2014.

Lack of reversibility for NOACs

Sadeer Al-Kindi  1
Affiliations

Lack of reversibility for NOACs

Sadeer Al-Kindi. Glob Cardiol Sci Pract. .
No abstract available

PubMed Disclaimer

References

    1. Kaba RA, Ahmed O, Cannie D. ENGAGE AF: Effective anticoagulation with factor Xa in next generation treatment of atrial fibrillation. Glob Cardiol Sci Pract. 2013;2013(4):354–356. - PMC - PubMed
    1. Dager WE, Gosselin RC, Kitchen S, Dwyre D. Dabigatran effects on the international normalized ratio, activated partial thromboplastin time, thrombin time, and fibrinogen: a multicenter, in vitro study. Ann Pharmacother. 2012 Dec;46(12):1627–1636. - PubMed
    1. Sarma A. Novel Oral Anticoagulants and Lack of Reversibility. Cardiosource.org. Accessed 1/11/2014.
    1. Laulicht B, Bakhru S, Lee C, Baker C, Jiang X, Mathiowitz E, Costin J, Steiner S. Small Molecule Antidote for Anticoagulants. Circulation. 2012 Nov;126(21S):A11395.
    1. Mark C, Vandana M, Michael K, Genmin L, Conley PB, Stanley H, Castillo J, Hutchaleelaha A, Karbarz M, Lin JP, Barron L, Russell S, Levy GG, Connolly S, Curnutte JT. A Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial Demonstrating Reversal Of Rivaroxaban-Induced Anticoagulation In Healthy Subjects By Andexanet Alfa (PRT064445), An Antidote For Fxa Inhibitors. Blood. 2013 Oct;122(21):3636.

LinkOut - more resources